Physician profile
Christopher Sullivan
NPI 1811008253
$471.17
in general payments reported to CMS, 2019-2025
10 companies · $72.80 in 2025
The $72.80 reported for 2025 was more than what a typical Maternal & Fetal Medicine provider received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.41 · 2021: $60.09 · 2022: $113 · 2023: $17.09 · 2024: $187 · 2025: $72.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $203 · Gift: $74.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $203.12 |
| Gift | $74.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $146.23 | 2024-2025 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Boston Scientific Corporation | $85.12 | 2022 | |
| Sonio | $74.00 | 2024 | |
| Medtronic, INC. | $60.09 | 2021 | |
| Sage Therapeutics, LLC | $27.43 | 2022 | |
| Smith+Nephew, INC. | $21.67 | 2025 | Pico 7, Pico 14 |
| Ge Healthcare | $21.41 | 2020 | |
| Merck Sharp & Dohme LLC | $18.13 | 2025 | Gardasil 9 |
| Insulet Corporation | $17.09 | 2023 | Omnipod |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.